This activity is jointly sponsored by Medical Learning Institute, Inc., a nonprofit medical accreditation company, and Center of Excellence Media, LLC.
This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.
Upon completion of this activity, the participant will be able to:
Commercial Support Acknowledgment
This activity is supported by an educational grant from Cephalon.
Instructions for Credit
There is no fee for this activity. After reading this CE activity in its entirety, participants must complete the posttest and evaluation. The posttest and evaluation can be completed online at www.mlicme.org/p10033.html. Upon completion of the evaluation and scoring 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the certificate for your records. For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc., at 609-333-1693 or email@example.com.
Medical Learning Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468-9999-10-014-H01-P.
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker’s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.
The associates of Medical Learning Institute, Inc., and Center of Excellence Media, LLC, have no financial relationships to disclose.
Dwight D. Kloth, PharmD, FCCP, BCOP, is on the Advisory Board of Amgen, Eisai, and Ortho-Biotech, and on the Speaker’s Bureau of Amgen. He discusses bendamustine plus rituximab combination.
Gary C. Yee, PharmD, FCCP, BCAP, is on the Advisory Board of Amgen and Eisai. He discusses bendamustine, bortezomib, ofatumumab, and temsirolimus.
Caroline Helwick has no financial relationships to disclose.
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
Estimated time to complete activity: 1 hour
Initial Release Date: April 15, 2010
Expiration Date: April 15, 2011